Immune Globulin Intravenous (Human), 10%
160601
Phase 3 small_molecule completed
Quick answer
Immune Globulin Intravenous (Human), 10% for Primary Immunodeficiency Diseases (PID) is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Primary Immunodeficiency Diseases (PID)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed